PHARMACEUTICAL PRODUCTS FIELD
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| DISRUPTIVE COSMETICS | CAPSUM | 126 Boulevard Bara Heliopolis II MARSEILLE 13013 France | Pharmaceutical products in the field of skin care; veterinary products, namely veterinary preparations for skin care for domestic pets; sanitary products for medical purposes; dietetic foods adapted for medical use; dietetic substances for medical use in the nature of dietetic beverages adapted for medical use; dietetic foodstuffs adapted for human use, for veterinary use and for medical use; food for babies; food supplements; Medical plasters in the nature of materials for dressings; teeth filling material; dental impression materials; disinfectants; products for destroying vermin; fungicides; herbicides; bath preparations for medical use; sanitary panties; sanitary towels; chemical preparations for medical use, namely, treatment of dermatological conditions; chemical preparations for pharmaceutical use, namely, treatment of dermatological conditions; medicinal herbs; herbal teas for medicinal purposes; parasiticides; alloys of precious metals for dental use;Skin whitening preparations; laundry detergents; polishing preparations; degreasing preparations for keratinic material, notably for skin or lips; abrasive preparations for keratinic material, notably for skin or lips; non-medicated soaps; perfumes; essential oils; cosmetics; hair lotions; dentifrices; depilatories; make-up removing products; lipstick; beauty masks; shaving products; leather preserving polishes; creams for leather;COSMETICS; |
| EXGILIA | IPSEN PHARMA S.A.S | 65, Quai Georges Gorse Boulogne Billancourt 92100 France | Pharmaceutical products in the field of oncology; |
| EXGILIA | IPSEN PHARMA S.A.S | 65, Quai Georges Gorse Boulogne Billancourt 92100 France | Pharmaceutical products in the field of oncology; |
| PERINESTA | ESTETRA | Rue Saint-Georges 5 B-4000 Liège Belgium | Pharmaceutical products in the field of gynecology and women's health, including for treating symptoms of perimenopause and menopause, namely, oral and chemical contraceptives, hormones for medical purposes, hormone replacement therapy preparations, estrogen preparations; oral contraceptives; chemical contraceptives; hormonal preparations for pharmaceutical use; contraceptives for treating symptoms of perimenopause and menopause, namely, oral contraceptives, contraceptive preparations and contraceptive foams;PERI NESTA;Pharmaceutical research and development services; testing on pharmaceutical products; carrying out clinical trials for others for pharmaceutical products; development of pharmaceutical preparations and medicines; consultancy with respect to pharmaceutical research and development; laboratory research services concerning pharmaceutical products; services for conducting early assessments of new pharmaceuticals, namely, testing of new pharmaceuticals; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; provision of information concerning the results of clinical trials for pharmaceutical products, namely, providing information on testing, inspection or research of pharmaceuticals; |
| VESIGEN | Vesigen, Inc. | 790 Memorial Drive, Suite 103 Cambridge MA 02139 | Pharmaceutical products in the field of extracellular vesicle delivery systems for the delivery of large macromocleules to cells, all of the foregoing for use by prescribing physicians and pharmacists in providing medical treatment; all of the foregoing excluding nutritional, dietary, and food supplements;Licensing of intellectual property rights to others, namely, intellectual property for use in developing extracellular vesicle delivery systems for the delivery of large macromocleules to cells, all of the foregoing excluding intellectual property for use in developing nutritional, dietary, and food supplements;Laboratory research services relating to pharmaceuticals, namely, research in the field of extracellular vesicle delivery systems for the delivery of large macromocleules to cell, all of the foregoing for use by physicians and medical researchers in providing medical treatment; all of the foregoing excluding research and development of nutritional, dietary, and food supplements; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- Media and processes for the fermentation of Clostridium botulinum and obtaining a botulinum toxin for use in formulating botulinum toxin pharmaceutical compositions. The growth media can contain significantly reduced levels of meat or dairy by-products using non-animal based products to replace the animal-derived products. Preferably, the media used are substantially free of animal derived products.